Skip to main content

Compliance with Medication in Nursing Homes for Older People

Resident Enforcement or Resident Empowerment?

Abstract

Compliance with medication has been frequently cited as a problem for patients living in community settings. However, there has been little commentary on compliance issues for residents in nursing homes. This is probably due to the assumption that residents will receive their medication on a regular basis and administration will be supervised and, therefore, compliance is not perceived to be a problem. However, regular compliance may not always be appropriate if the medication has not been reviewed for appropriateness and this ‘enforced’ compliance may give rise to side effects or adverse effects. Residents may also be exposed to ‘erratic’ compliance because of inconvenient administration times for staff or difficult and time-consuming administration instructions. This may have clinical implications for residents who require medication at regular intervals, e.g. those who have Parkinson’s disease. Enforced or erratic compliance is at odds with shared decision making, which is being promoted as a way of empowering patients. It could be argued that because of a high degree of cognitive impairment, it is not appropriate for nursing home residents to become involved in decision making about medications. However, the nursing home population is heterogeneous in nature and the assumption should not be made that all residents are incapable of becoming more involved in some aspects of their own care. A greater focus on resident-centred care may promote more empowerment and autonomy, both generally and with respect to compliance with medication in particular, in nursing home residents.

This is a preview of subscription content, access via your institution.

Table I

References

  1. Institute of Medicine. Improving the quality of care in nursing homes. Washington, DC: National Academy Press, 1986

    Google Scholar 

  2. Institute of Medicine. Improving the quality of long-term care. Washington, DC: National Academy Press, 2001

    Google Scholar 

  3. Avorn J, Dreyer P, Connelly K, et al. Use of psychoactive medication and the quality of care in rest homes. N Engl J Med 1989; 320: 227–32

    PubMed  Article  CAS  Google Scholar 

  4. Board of Directors of the American Association for Geriatric Psychiatry. Psychotherapeutic medications in the nursing home. J Am Geriatr Soc 1992; 40: 946–9

    Google Scholar 

  5. Hughes CM, Lapane KL, Mor V, et al. The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. J Am Geriatr Soc 2000; 48: 931–7

    PubMed  CAS  Google Scholar 

  6. Lapane KL, Hughes CM. Optimizing drug utilization in long-term care: the case of coronary heart disease. Pharmacoeconomics 2002; 20: 143–52

    PubMed  Article  Google Scholar 

  7. Haynes RB. Determinants of compliance: the disease and the mechanics in treatment. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore (MD): Johns Hopkins University Press, 1979: 3–18

    Google Scholar 

  8. Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging 2004; 21: 793–811

    PubMed  Article  Google Scholar 

  9. Haynes RB, Yao X, Degani A, et al. Interventions to enhance medication adherence. Cochrane Database Syst Rev 2005; (4): CD000011

    Google Scholar 

  10. World Health Organization (WHO). Adherence to long-term therapies: evidence for action. Geneva: WHO, 2003

    Google Scholar 

  11. Compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain and Merck Sharp & Dohme, 1997

  12. Britten N, Weiss M, What is concordance? In: Bond CM, editor. Concordance. London: The Pharmaceutical Press, 2004: 9–28

    Google Scholar 

  13. Lapane KL, Hughes CM. An evaluation of the impact of the prospective payment system on antidepressant use in nursing home residents. Med Care 2004; 42: 48–58

    PubMed  Article  Google Scholar 

  14. Fahey T, Montgomery AA, Barnes J, et al. Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. BMJ 2003; 326: 580–4

    PubMed  Article  Google Scholar 

  15. Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing homes residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care 2003; 12: 176–80

    PubMed  Article  CAS  Google Scholar 

  16. Niwata S, Yamada Y, Ikegami N. Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities. BMC Geriatrics 2006; 6: 1

    PubMed  Article  Google Scholar 

  17. Bellelli G, Frisoni GB, Barbisoni P, et al. The management of adverse clinical events in nursing homes: a 1-year survey. J Am Geriatr Soc 2001; 49: 915–25

    PubMed  Article  CAS  Google Scholar 

  18. Snowden J, Day S, Baker W. Audits of medication use in Sydney nursing homes. Age Ageing 2006; 35: 403–8

    Article  Google Scholar 

  19. Schweizer AK, Hughes CM, Curran ML. Is psychoactive medication usage in care homes related to staffing levels? [abstract]. Int J Pharm Pract 2003; 11: R42

    Google Scholar 

  20. O’Grady M, Weedle P. A descriptive study of drug therapy and cost for elderly residents in a nursing home. Ir Med J 1998; 91: 172–4

    PubMed  Google Scholar 

  21. Bergman A, Olsson J, Carlsten A, et al. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care 2007; 25: 9–14

    PubMed  Article  Google Scholar 

  22. NICE. Hypertension: management of hypertension in adults in primary care. London: NICE, 2004

    Google Scholar 

  23. NICE. Statins for the prevention of cardiovascular events: technology appraisal, 94. London: NICE, 2006

    Google Scholar 

  24. Patrano C, Cooler B, Fitzgerald GA, et al. Platelet-active drugs: the relationships among dose, effectiveness and side-effects. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 234S–64S

    Article  Google Scholar 

  25. Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004; 164: 1957–9

    PubMed  Article  Google Scholar 

  26. Hutchins LF, Unger JM, Crowley JJ, et al. Under-representation of patients 65 years of age or older in cancer treatment trials. N Engl J Med 1999; 341: 2061–7

    PubMed  Article  CAS  Google Scholar 

  27. Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708–13

    PubMed  Article  CAS  Google Scholar 

  28. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167: 781–7

    PubMed  Article  Google Scholar 

  29. Gao X, Nau DP, Rosenbluth SA, et al. The relationship of disease severity, health beliefs and medication adherence among HIV subjects. AIDS Care 2000; 12: 387–98

    PubMed  Article  CAS  Google Scholar 

  30. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy non-compliance and patient characteristics, health-related quality of life and healthcare costs. Pharmacotherapy 2000; 20: 941–9

    PubMed  Article  CAS  Google Scholar 

  31. Kripalani S, Yao X, Haynes B. Interventions to enhance medication adherence in chronic medical conditions. Arch Intern Med 2007; 167: 540–50

    PubMed  Article  Google Scholar 

  32. Weintraub M. Intelligent non-compliance with special emphasis on the elderly. Contemp Pharm Pract 1980; 4: 8–11

    Google Scholar 

  33. Mattiasson AC, Andersson L. Quality of nursing home care assessed by competent nursing home patients. J Adv Nursing 1997; 26: 1117–24

    CAS  Google Scholar 

  34. Office of the Inspector General, US Department of Health and Human Services (DHHS). Prescription drug use in nursing homes. In: report 2: an inside view by consultant pharmacists (report no. OEI-06-96-00081). Washington, DC: DHHS, 1997

    Google Scholar 

  35. Barnes L, Cheek J, Nation RL, et al. Making sure the residents get their tablets: medication administration in care homes for older people. J Adv Nurs 2006; 56: 190–9

    PubMed  Article  Google Scholar 

  36. Rochon P, Gurwitz JH. Optimizing drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315: 1096–9

    PubMed  Article  CAS  Google Scholar 

  37. Gurwitz J, Field T, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87–94

    PubMed  Article  CAS  Google Scholar 

  38. Kirkevold O, Engedal K. Concealment of drugs in food and beverages in nursing homes: cross sectional study. BMJ 2005; 330: 20–3

    PubMed  Article  Google Scholar 

  39. Treloar A, Beats B, Philpot M. A pill in the sandwich: covert medication in food and drink. J Roy Soc Med 2000; 93: 408–11

    PubMed  CAS  Google Scholar 

  40. Macdonald A, Roberts A, Carpenter I. De facto imprisonment and covert medication use in general nursing homes for older people in South East England. Aging Clin Exp Res 2004; 16: 326–30

    PubMed  Google Scholar 

  41. Treloar A, Philpot M, Beats B. Concealing medication in patients’ food. Lancet 2001; 357: 62–4

    PubMed  Article  CAS  Google Scholar 

  42. Hughes CM, Lapane K, Mor V. The impact of legislation on nursing home care in the United States: lessons for the United Kingdom. BMJ 1999; 319: 1060–3

    PubMed  Article  CAS  Google Scholar 

  43. Hughes CM, Lapane KL. Administrative initiatives to reduce inappropriate prescribing of psychotropics in nursing homes: how successful have they been? Drugs Aging 2005; 22: 339–51

    PubMed  Article  Google Scholar 

  44. Nursing and Midwifery Council [online]. Available from URL: http://www.nmc-uk.org [Accessed 2007 May 17]

  45. Urquhart J, Vrijens B. Patient adherence to prescribed drug dosing regimens in ambulatory pharmacotherapy. In: Strom BL, Kimmel SE, editors. Textbook of pharmacoepidemiology. Chichester: Wiley, 2006: 367–83

    Google Scholar 

  46. Urquhart J. Partial compliance in cardiovascular disease: risk implications. Br J Clin Pract Suppl 1994; 73: 2–12

    PubMed  CAS  Google Scholar 

  47. Stephenson BJ, Rowe BH, Haynes RB, et al. Is this patient taking the treatment as prescribed? JAMA 1993; 269: 2779–81

    PubMed  Article  CAS  Google Scholar 

  48. Feldman RG, Kaye JA, Lannon MC. Parkinson’s disease: follow-up after ‘drug holiday’. J Clin Pharmacol 1985; 26: 662–7

    Google Scholar 

  49. Corona T, Rivera C, Otero E, et al. A longitudinal study of the effects of an L-dopa drug holiday in the course of Parkinson’s disease. Clin Neuropharmacol 1995; 18: 325–32

    PubMed  Article  CAS  Google Scholar 

  50. Leopold NA, Polansky M, Hurka MR. Drug adherence in Parkinson’s disease. Move Disord 2004; 19: 513–7

    Article  Google Scholar 

  51. Grosset KA, Bone I, Grosset DG. Suboptimal medication adherence in Parkinson’s disease. Move Disord 2005; 20: 1502–7

    Article  Google Scholar 

  52. Grosset KA, Reid JL, Grosset DG. Medicine-taking behaviour: implications of suboptimal compliance in Parkinson’s disease. Move Disord 2005; 20: 1397–404

    Article  Google Scholar 

  53. Verweij MF, van den Hoven MA. Influenza vaccination in Dutch nursing homes: is tacit consent morally justified? Med Health Care Phil 2005; 8: 89–95

    Article  CAS  Google Scholar 

  54. Stabell A, Eide H, Solheim GA, et al. Nursing homes residents’ dependence and independence. J Clin Nurs 2004; 13: 677–86

    PubMed  Article  Google Scholar 

  55. Nijs KAND, de Graaf C, Kok FJ, et al. Effect of family style mealtimes on quality of life, physical performance, and body weight of nursing home residents: cluster randomised controlled trial. BMJ 2006; 332: 1180–4

    PubMed  Article  Google Scholar 

  56. Grau L, Chandler B, Saunders C. Nursing home residents’ perceptions of the quality of their care. J Psychosoc Nurs 1995; 33: 34–41

    CAS  Google Scholar 

  57. Flesner MK, Rantz MJ. Mutual empowerment and respect: effect on nursing home quality of care. J Nurs Care Qual 2004; 21: 354–61

    Google Scholar 

  58. Andrews GJ, Homes D, Poland B, et al. ‘Airplanes are flying nursing homes’: geographies in the concepts and locales of gerontological nursing practice. J Clin Nurs 2005; 14: 109–20

    PubMed  Article  Google Scholar 

  59. Matthews FE, Dening T; UK Medical Research Council Cognitive Function and Ageing Study. Prevalence of dementia in institutional care. Lancet 2002; 360: 225–6

    PubMed  Article  Google Scholar 

  60. Magaziner J, German P, Zimmerman SI, et al. The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: diagnosis by expert panel. Epidemiology of Dementia in Nursing Homes Research Group. Gerontologist 2000; 40: 663–72

    PubMed  Article  CAS  Google Scholar 

  61. Baiyewu O, Adeyami JD, Ogunniyi A. Psychiatric disorders in Nigerian nursing home residents. Int J Geriatr Psych 1009; 12: 1146–50

    Article  Google Scholar 

  62. Wancata J, Benda N, Meise U, et al. Non-cognitive symptoms of dementia in nursing homes: frequency, course and consequences. Soc Psychiatry Psychiatr Epidemiol 2003; 38: 637–43

    PubMed  Article  Google Scholar 

  63. Quinn ME, Johnson MA, Andress EL, et al. Health characteristics of elderly residents in personal care homes. J Gerontol Nurs 2003; 29: 16–23

    PubMed  Google Scholar 

  64. Department of Health. English national minimum standards for care homes. London: The Stationery Office, 2003

    Google Scholar 

  65. The expert patients programme [online]. Available from URL: http://www.expertpatients.nhs.uk [Accessed 2007 Aug 6]

  66. Coulter A. Paternalism or partnership. BMJ 1999; 319: 719–20

    PubMed  Article  CAS  Google Scholar 

  67. Lothian K, Philp I. Maintaining the dignity and autonomy of older people in the healthcare setting. BMJ 2001; 322: 668–70

    PubMed  Article  CAS  Google Scholar 

  68. Coulter A, Ellins J. Effectiveness of strategies for informing, educating and involving patients. BMJ 2007; 335: 24–7

    PubMed  Article  Google Scholar 

  69. Aujoulat I, d’Hoore W, Deccache A. Patient empowerment in theory and practice: polysemy or cacophony? Patient Educ Couns 2007; 66: 13–20

    PubMed  Article  Google Scholar 

  70. Sacco-Peterson M, Borell L. Struggles for autonomy in self-care: the impact of the physical and socio-cultural environment in a long-term care setting. Scand J Caring Sci 2004; 18: 376–86

    PubMed  Article  Google Scholar 

  71. McCormack B. A conceptual framework for person-centred practice with older people. Int J Nurs Pract 2003; 9: 202–9

    PubMed  Article  Google Scholar 

  72. Cohen-Mansfield J, Bester A. Flexibility as a management principle in dementia care: the Adards example. Gerontologist 2006; 46: 540–4

    PubMed  Article  Google Scholar 

  73. Train GH, Nurock SA, Manela M, et al. A qualitative study of the experiences of long-term care for residents with dementia, their relatives and staff. Aging Ment Health 2005; 9: 119–28

    PubMed  CAS  Google Scholar 

  74. Mullins LC, Hartley TM. Residents’ autonomy: nursing homes personnel’s perceptions. J Gerontol Nurs 2002; 28: 35–44

    PubMed  Google Scholar 

  75. Krause M. Medication administration in a resident-centred nursing home. Am J Nurs 2006; 75: 6

    Google Scholar 

  76. Dewing J, Garner P. Listening to Enid. Elder Care 1998; 10: 12–5

    PubMed  CAS  Google Scholar 

  77. Tellis-Nayak V. A person-centred workplace: the foundation for person-centred caregiving in long-term care. J Am Med Dir Assoc 2007; 8: 46–54

    PubMed  Article  CAS  Google Scholar 

  78. Tuckett A. On paternalism, autonomy and best interests: telling the (competent) aged-care resident what they want to know. Int J Nurs Pract 2006; 12: 166–73

    PubMed  Article  Google Scholar 

  79. Zweibel N, Cassel N. Treatment choices at the end of life: comparisons of decisions by older patients and their physician selected proxies. Gerontologist 1989; 29: 615–21

    PubMed  Article  CAS  Google Scholar 

  80. Hurtley R. Care home ‘habilitation’ the Eden Alternative. Nurs Residential Care 2007; 9: 70–2

    Google Scholar 

  81. Kehoe MA, Heesch B. Culture change in long term care: the Wellspring model. J Soc Work Long Term Care 2003; 2: 159–73

    Article  Google Scholar 

  82. Rabig J, Thomas W, Kane RA, et al. Radical redesign of nursing homes: applying the Green House concept in Tupelo Mississippi. Gerontologist 2006; 46: 533–9

    PubMed  Article  Google Scholar 

  83. Bergman Evans B. Beyond the basics: effects of the Eden Alternative Model on quality of life issues. J Gerontol Nurs 2004; 30: 27–34

    PubMed  Google Scholar 

Download references

Acknowledgements

At the time of writing, Carmel M. Hughes was supported by a Cochrane Fellowship from the Research and Development Office, Northern Ireland and a grant from Atlantic Philanthropies to conduct a study on compliance with medication in nursing homes for older people. The author has no conflicts of interest that are directly relevant to the content of this article.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Carmel M. Hughes.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hughes, C.M. Compliance with Medication in Nursing Homes for Older People. Drugs Aging 25, 445–454 (2008). https://doi.org/10.2165/00002512-200825060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200825060-00001

Keywords

  • Dementia
  • Nursing Home Resident
  • Trandolapril
  • Residential Home
  • Nursing Home Population